INmune Bio (INMB) Reports Key Findings from Phase 2 MINDFuL Trial of XPro

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to INmune Bio (INMB) Reports Key Findings from Phase 2 MINDFuL Trial of XPro
(NASDAQ: INMB) Delayed: 1.42 -0.01 (0.7%)
Previous Close $1.43    52 Week High $ 
Open $1.39    52 Week Low $ 
Day High $1.50    P/E N/A 
Day Low $1.39    EPS $ 
Volume 418,225